PULMONX CORPORATION Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $201.00K, a 63.72% decline year-over-year.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $200.00K, a 53.60% decline year-over-year.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $554.00K, a 31.44% decline year-over-year.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $431.00K, a 15.16% decline year-over-year.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2025 was $754.00K, a 39.19% decline from fiscal 2024.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.24M, a 4.73% increase from fiscal 2023.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.18M, a 39.03% decline from fiscal 2022.
- PULMONX CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.94M, a 26.77% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $201.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $754.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $554.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $1.24M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $431.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $808.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $1.18M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $508.00K 10-Q · filed 2024-11-01 | |
| 2023-03-31 | $676.00K 10-Q · filed 2024-11-01 | |
| 2022-12-31 | $1.94M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $834.00K 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $1.11M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $2.65M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $660.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.99M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |